Capgemini acquires digital customer engagement specialist LiquidHub

By Jonathan Dyble
Capgemini has announced that it has acquired digital customer engagement firm LiquidHub in a deal worth €400mn (USD$498.1mn), twice the value of Liqui...

Capgemini has announced that it has acquired digital customer engagement firm LiquidHub in a deal worth €400mn (USD$498.1mn), twice the value of LiquidHub’s 2017 revenue.

LiquidHub has developed a number of specialised platforms in order to execute complete customer engagement, such as its Speciality Pharma Insights Platform. This aligns a number of channels across the pharmaceutical industry, from patients to providers, providing a more seamless experience for all parties.

See also:

“LiquidHub’s passion to help clients uncover new ways to engage with their customers, supported by robust digital expertise and a strong track record in complex technology execution, was a natural fit with the end to end digital services that Capgemini provides enterprises around the world,” comments Paul Hermelin, Chairman and CEO, Capgemini Group.

“The team’s customer centric mindset was evident, and its impressive employee retention record is a testament to the strength of LiquidHub’s purpose, vision and values that are complementary to those of Capgemini.”

The acquisition accelerates the company’s ongoing portfolio shift strategy, with a particular focus on digital and cloud, whilst also reinforcing the expansion of its digital consulting capabilities across North America.

The transaction is set to close in the next couple of months.

Share
Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain